MetaCap

Annovis Bio (ANVS) News

NYSE: ANVSHealth CareBiotechnology: Pharmaceutical PreparationsUSD

0.7113-0.0371 (-4.96%)

At close: Nov 20, 4:00 PM ET · Delayed 15 min

ANVS news summary

We found 11 recent headlines mentioning Annovis Bio (ANVS): 3 in the past week and 10 in the past 30 days, most often from GlobeNewswire, Nasdaq. For price context, ANVS is down 4.96% at $0.7113. The most recent story, "Annovis Bio To Pool Safety Data From Four Buntanetap Studies Following FDA Agreement", was published by Nasdaq on Nov 20, 2026.

Headlines link to the original publishers. MetaCap does not republish third-party articles.

Summary generated from market data by MetaCap's automated system. Methodology

Latest Annovis Bio headlines

Stocks mentioned alongside ANVS

Compare ANVS